PART II – OTHER INFORMATION 



Item 1.
Legal Proceedings 



The information regarding certain legal proceedings in which we are involved as set forth in Note 14 – Commitments and Contingencies of the Notes to the Condensed Consolidated Financial Statements (Part I, Item 1 of this Quarterly Report on Form 10-Q) is incorporated by reference into this Item 1.
In addition, we are involved in various other legal proceedings arising in the normal course of our businesses.
At this time, we do not believe any material losses under these claims to be probable.
While the ultimate outcome of such legal proceedings cannot be predicted with certainty, it is in the opinion of management, after consultation with legal counsel, that the final outcome in such proceedings, in the aggregate, would not have a material adverse effect on our consolidated financial condition, results of operations or cash flows.
Item 1A.
“Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2018.
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds 



The following is a summary of the repurchases of our common stock in the third quarter of 2019 (in millions, except average price per share): 



 [DATA_TABLE_REMOVED] 



(1)  



Information is based on trade dates of repurchase transactions.
(2)  



Represents shares repurchased in open market transactions pursuant to the Common Stock Repurchase Program 



(3)  



Share repurchases were made pursuant to our Common Stock Repurchase Program authorized by our Board of Directors on August 8, 2019.
The program allows for the purchase of up to $500 million of outstanding common stock in one or more transactions on the open market or in privately negotiated purchases.
Item 6.
Exhibits 



The exhibits listed in the Exhibit Index immediately preceding such exhibits are filed as part of this Report.
29 



EXHIBIT INDEX 



 [DATA_TABLE_REMOVED] 



*  



Filed herewith.
30
